| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | Leads this displayed comparison. Source-reported ± 2.50 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #2 of 24 in this displayed comparison; 3.3 pp below the leader. Source-reported ± 2.90 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #2 of 24 in this displayed comparison; 3.3 pp below the leader. Source-reported ± 1.90 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #4 of 24 in this displayed comparison; 6.5 pp below the leader. Source-reported ± 2.10 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #5 of 24 in this displayed comparison; 12.2 pp below the leader. Source-reported ± 0.70 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #6 of 24 in this displayed comparison; 15 pp below the leader. Source-reported ± 2.40 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #7 of 24 in this displayed comparison; 17.1 pp below the leader. Source-reported ± 4.30 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #8 of 24 in this displayed comparison; 18.66 pp below the leader. Source-reported ± 0.70 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #9 of 24 in this displayed comparison; 18.7 pp below the leader. Source-reported ± 2.40 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #10 of 24 in this displayed comparison; 19.9 pp below the leader. Source-reported ± 2.10 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #11 of 24 in this displayed comparison; 21.9 pp below the leader. Source-reported ± 1.40 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #12 of 24 in this displayed comparison; 23.6 pp below the leader. Source-reported ± 4.38 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #12 of 24 in this displayed comparison; 23.6 pp below the leader. Source-reported ± 4.90 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #14 of 24 in this displayed comparison; 24 pp below the leader. Source-reported ± 1.90 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #15 of 24 in this displayed comparison; 26.8 pp below the leader. Source-reported ± 4.60 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #16 of 24 in this displayed comparison; 32.5 pp below the leader. Source-reported ± 3.70 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #17 of 24 in this displayed comparison; 33.4 pp below the leader. Source-reported ± 2.10 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #18 of 24 in this displayed comparison; 37 pp below the leader. Source-reported ± 3.20 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #19 of 24 in this displayed comparison; 37.4 pp below the leader. Source-reported ± 0.70 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #20 of 24 in this displayed comparison; 39.4 pp below the leader. Source-reported ± 3.20 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #20 of 24 in this displayed comparison; 39.4 pp below the leader. Source-reported ± 2.50 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #22 of 24 in this displayed comparison; 41 pp below the leader. Source-reported ± 6.70 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #23 of 24 in this displayed comparison; 44.7 pp below the leader. Source-reported ± 0.70 percentage points (definition follows the source) |
|---|
| 1 report | DrugDiscoveryBench[1]Source-displayed model and agent configuration | #24 of 24 in this displayed comparison; 45.9 pp below the leader. Source-reported ± 4.60 percentage points (definition follows the source) |
|---|